Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct-Dec;7(4):218.
doi: 10.4103/sajc.sajc_53_18.

Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients

Affiliations

Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients

Vishwanath Singh Yadav et al. South Asian J Cancer. 2018 Oct-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Mandell GL, Dolin R. Principles and Practice of Infective Disease. 6thed. New York: Elsevier; 2005. pp. 2757–9.
    1. Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol. 2005;43:2021–3. - PMC - PubMed
    1. Monteen MR, Ponnapula S, Wood GC, Croce MA, Swanson JM, Boucher BA, et al. Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient. Ann Pharmacother. 2013;47:1736–9. - PubMed
    1. Bhuyar G, Jain S, Shah H, Mehta VK. Urinary tract infection by Chryseobacterium indologenes. Indian J Med Microbiol. 2012;30:370–2. - PubMed
    1. Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother. 1997;41:2738–41. - PMC - PubMed